Longitudinal Changes in Anger, Anxiety, and Fatigue Are Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease

被引：10
|
作者：
Babulal, Ganesh M. [1 ,2 ,3 ,4 ]
Chen, Ling [5 ]
Doherty, Jason M. [1 ]
Murphy, Samantha A. [1 ]
Johnson, Ann M. [6 ]
Roe, Catherine M. [1 ]
机构：
[1] Washington Univ, Dept Neurol, St Louis, MO 63110 USA
[2] Washington Univ, Inst Publ Hlth, St Louis, MO 63110 USA
[3] Univ Johannesburg, Fac Humanities, Dept Psychol, Johannesburg, South Africa
[4] George Washington Univ, Sch Med & Hlth Sci, Dept Clin Res & Leadership, Washington, DC 20052 USA
[5] Washington Univ, Div Biostat, St Louis, MO 63110 USA
[6] Washington Univ, Ctr Clin Studies, St Louis, MO 63110 USA
来源：
JOURNAL OF ALZHEIMERS DISEASE | 2022年 / 87卷 / 01期
关键词：
Alzheimer's disease; anger; anxiety; biomarkers; cerebrospinal fluid; older adults; MILD BEHAVIORAL IMPAIRMENT; COGNITIVE IMPAIRMENT; DEPRESSIVE SYMPTOMS; OLDER-ADULTS; DEMENTIA; TAU; NEURODEGENERATION; PREVALENCE; PROFILE; DECLINE;
D O I：
10.3233/JAD-215708
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Alzheimer's disease (AD) studies in cognitively normal (CN) older adults age >= 65 suggest depression is associated with molecular biomarkers (imaging and cerebrospinal fluid [CSF]). This study used linear mixed models (covariance pattern model) to assess whether baseline CSF biomarkers (A beta(42)/A beta(40), t-Tau/A beta(42) , p-Tau/A beta(42)) predicted changes in non-depressed mood states in CN older adults (N= 248), with an average of three follow-up years. Participants with higher levels of CSF biomarkers developed more anger, anxiety, and fatigue over time compared to those with more normal levels. Non-depressed mood states in preclinical AD may be a prodrome for neuropsychiatric symptoms in symptomatic AD.
引用
收藏
页码：141 / 148
页数：8
相关论文
共 50 条
  • [1] Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease
    Bos, Isabelle
    Vos, Stephanie J. B.
    Schindler, Suzanne E.
    Hassenstab, Jason
    Xiong, Chengjie
    Grant, Elizabeth
    Verhey, Frans
    Morris, John C.
    Visser, Pieter Jelle
    Fagan, Anne M.
    ALZHEIMERS & DEMENTIA, 2019, 15 (09) : 1149 - 1159
  • [2] Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers
    Bridel, Claire
    Somers, Charisse
    Sieben, Anne
    Rozemuller, Annemieke
    Niemantsverdriet, Ellis
    Struyfs, Hanne
    Vermeiren, Yannick
    Van Broeckhoven, Christine
    De Deyn, Peter P.
    Bjerke, Maria
    Nagels, Guy
    Teunissen, Charlotte E.
    Engelborghs, Sebastiaan
    BRAIN, 2022, 145 (11) : 4056 - 4064
  • [3] Cerebrospinal fluid biomarkers of Alzheimer's disease
    Fagan, Anne M.
    Holtzman, David M.
    BIOMARKERS IN MEDICINE, 2010, 4 (01) : 51 - 63
  • [4] Cerebrospinal Fluid Biomarkers for Alzheimer's Disease
    Blennow, Kaj
    Zetterberg, Henrik
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 18 (02) : 413 - 417
  • [5] Clinical use of cerebrospinal fluid biomarkers in Alzheimer's disease
    Zetterberg, Henrik
    Lunn, Michael P.
    Herukka, Sanna-Kaisa
    BIOMARKERS IN MEDICINE, 2012, 6 (04) : 371 - 376
  • [6] A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Belgium
    Somers, Charisse
    Struyfs, Hanne
    Goossens, Joery
    Niemantsverdriet, Ellis
    Luyckx, Jill
    De Roeck, Naomi
    De Roeck, Ellen
    De Vil, Bart
    Cras, Patrick
    Martin, Jean-Jacques
    De Deyn, Peter-Paul
    Bjerke, Maria
    Engelborghs, Sebastiaan
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 54 (01) : 383 - 395
  • [7] Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease Study
    Dage, Jeffrey
    Eloyan, Ani
    Thangarajah, Maryanne
    Hammers, Dustin B.
    Fagan, Anne M.
    Gray, Julia D.
    Schindler, Suzanne E.
    Snoddy, Casey
    Nudelman, Kelly N. H.
    Faber, Kelley M.
    Foroud, Tatiana
    Aisen, Paul
    Griffin, Percy T.
    Grinberg, Lea T.
    Iaccarino, Leonardo
    Kirby, Kala
    Kramer, Joel
    Koeppe, Robert A.
    Kukull, Walter A.
    La Joie, Renaud
    Mundada, Nidhi S.
    Murray, Melissa E.
    Rumbaugh, Malia
    Soleimani-Meigooni, David N.
    Toga, Arthur W.
    Touroutoglou, Alexandra
    Vemuri, Prashanthi
    Atri, Alireza A.
    Beckett, Laurel A.
    Day, Gregory S.
    Graff-Radford, Neill R.
    Duara, Ranjan S.
    Honig, Lawrence S.
    Jones, David T.
    Masdeu, Joseph C.
    Mendez, Mario F.
    Musiek, Erik
    Onyike, Chiadi U.
    Riddle, Meghan
    Rogalski, Emily
    Salloway, Stephen
    Sha, Sharon J.
    Turner, Raymond S.
    Wingo, Thomas S.
    Wolk, David A.
    Womack, Kyle B.
    Carrillo, Maria C.
    Dickerson, Bradford C.
    Rabinovici, Gil D.
    Apostolova, Liana G.
    ALZHEIMERS & DEMENTIA, 2023, 19 : S115 - S125
  • [8] Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease
    Schindler, Suzanne E.
    Li, Yan
    Todd, Kaitlin W.
    Herries, Elizabeth M.
    Henson, Rachel L.
    Gray, Julia D.
    Wang, Guoqiao
    Graham, Danielle L.
    Shaw, Leslie M.
    Trojanowski, John Q.
    Hassenstab, Jason J.
    Benzinger, Tammie L. S.
    Cruchaga, Carlos
    Jucker, Mathias
    Levin, Johannes
    Chhatwal, Jasmeer P.
    Noble, James M.
    Ringman, John M.
    Graff-Radford, Neill R.
    Holtzman, David M.
    Ladenson, Jack H.
    Morris, John C.
    Bateman, Randall J.
    Xiong, Chengjie
    Fagan, Anne M.
    ALZHEIMERS & DEMENTIA, 2019, 15 (05) : 655 - 665
  • [9] Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis
    Bjerke, Maria
    Engelborghs, Sebastiaan
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 62 (03) : 1199 - 1209
  • [10] Cerebrospinal fluid biomarkers of Alzheimer’s disease
    Xiaojing Sui
    Jianjun Liu
    Xifei Yang
    Neuroscience Bulletin, 2014, 30 : 233 - 242
12345